Anti-NUP93 monoclonal antibody

Pre-made anti-NUP93 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NUP93/NUP93 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1291-Ab-1/ GM-Tg-hg-IP1291-Ab-2Anti-Human NUP93 monoclonal antibodyHuman
GM-Tg-rg-IP1291-Ab-1/ GM-Tg-rg-IP1291-Ab-2Anti-Rat NUP93 monoclonal antibodyRat
GM-Tg-mg-IP1291-Ab-1/ GM-Tg-mg-IP1291-Ab-2Anti-Mouse NUP93 monoclonal antibodyMouse
GM-Tg-cynog-IP1291-Ab-1/ GM-Tg-cynog-IP1291-Ab-2Anti-Cynomolgus/ Rhesus macaque NUP93 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1291-Ab-1/ GM-Tg-felg-IP1291-Ab-2Anti-Feline NUP93 monoclonal antibodyFeline
GM-Tg-cang-IP1291-Ab-1/ GM-Tg-cang-IP1291-Ab-2Anti-Canine NUP93 monoclonal antibodyCanine
GM-Tg-bovg-IP1291-Ab-1/ GM-Tg-bovg-IP1291-Ab-2Anti-Bovine NUP93 monoclonal antibodyBovine
GM-Tg-equg-IP1291-Ab-1/ GM-Tg-equg-IP1291-Ab-2Anti-Equine NUP93 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1291-Ab-1/ GM-Tg-hg-IP1291-Ab-2; GM-Tg-rg-IP1291-Ab-1/ GM-Tg-rg-IP1291-Ab-2;
GM-Tg-mg-IP1291-Ab-1/ GM-Tg-mg-IP1291-Ab-2; GM-Tg-cynog-IP1291-Ab-1/ GM-Tg-cynog-IP1291-Ab-2;
GM-Tg-felg-IP1291-Ab-1/ GM-Tg-felg-IP1291-Ab-2; GM-Tg-cang-IP1291-Ab-1/ GM-Tg-cang-IP1291-Ab-2;
GM-Tg-bovg-IP1291-Ab-1/ GM-Tg-bovg-IP1291-Ab-2; GM-Tg-equg-IP1291-Ab-1/ GM-Tg-equg-IP1291-Ab-2
Products NameAnti-NUP93 monoclonal antibody
Formatmab
Target NameNUP93
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NUP93 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1291-Ag-1Recombinant multi-species NUP93/ NIC96 protein


    Target information

    Target IDGM-IP1291
    Target NameNUP93
    Gene ID9688,71805,291874,710084,478119,101081850,510004,100051892
    Gene Symbol and Synonyms2410008G02Rik,NIC96,NUP93
    Uniprot AccessionQ8N1F7,Q66HC5,A5PJZ5
    Uniprot Entry NameNUP93_HUMAN,NUP93_RAT,NUP93_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000102900
    Target ClassificationN/A

    The target: NUP93, gene name: NUP93, also named as NIC96. The nuclear pore complex is a massive structure that extends across the nuclear envelope, forming a gateway that regulates the flow of macromolecules between the nucleus and the cytoplasm. Nucleoporins are the main components of the nuclear pore complex in eukaryotic cells. This gene encodes a nucleoporin protein that localizes both to the basket of the pore and to the nuclear entry of the central gated channel of the pore. The encoded protein is a target of caspase cysteine proteases that play a central role in programmed cell death by apoptosis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.